Xencor



Ebitda Veränderung Datum
AbbVie USD 6.92B 258M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Arrowhead Research USD -156177000 1M 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Cytokinetics USD -136657000 1.73M 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
J&J USD 6.12B 1.51B 2024-12
MacroGenics USD 56.03M 112.4M 2024-09
Merck USD 7.12B 1.06B 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Xencor USD 7.14M 64.97M 2024-12



Xencor - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.